Header cover image

Israeli (TA) Pharma Industry Analysis

UpdatedJun 08, 2023
DataAggregated Company Financials
Companies7
  • 7D-0.2%
  • 3M-11.6%
  • 1Y-56.6%
  • YTD-24.1%

Over the last 7 days, the Pharma industry has dropped 4.4%, driven by Rekah Pharmaceutical Industry declining 4.2%. The industry has fallen 57% in the last year. As for the next few years, earnings are expected to grow by 47% per annum.

Industry Valuation and Performance

Has the Israeli Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 08 Jun 2023₪764.0m₪912.7m-₪126,083,550.0010.7x-6.1x0.8x
Sat, 06 May 2023₪809.8m₪887.2m-₪121,564,353.008x-6.7x0.9x
Mon, 03 Apr 2023₪825.0m₪829.2m-₪97,816,963.0011.8x-8.4x1x
Wed, 01 Mar 2023₪884.5m₪815.6m-₪71,871,197.0013.1x-12.3x1.1x
Fri, 27 Jan 2023₪1.0b₪739.7m-₪55,460,875.0017.1x-18.3x1.4x
Sun, 25 Dec 2022₪1.1b₪739.7m-₪57,339,450.0018.6x-18.3x1.4x
Tue, 22 Nov 2022₪1.3b₪728.3m-₪56,958,700.0023x-22.4x1.7x
Thu, 20 Oct 2022₪1.3b₪689.4m-₪60,709,999.0032.2x-21.6x1.9x
Sat, 17 Sep 2022₪1.4b₪785.2m-₪111,018,599.0029.1x-12.2x1.7x
Mon, 15 Aug 2022₪1.6b₪731.4m-₪114,950,081.0045.1x-14.1x2.2x
Wed, 13 Jul 2022₪1.6b₪731.4m-₪119,567,221.0044.7x-13.3x2.2x
Fri, 10 Jun 2022₪1.7b₪731.4m-₪117,313,233.0042.4x-14.3x2.3x
Sun, 08 May 2022₪1.7b₪669.4m-₪123,890,896.0036.8x-13.8x2.5x
Tue, 05 Apr 2022₪2.0b₪609.9m-₪107,325,594.0039.6x-18.3x3.2x
Thu, 03 Mar 2022₪1.9b₪598.9m-₪111,468,951.0047.5x-16.8x3.1x
Sat, 29 Jan 2022₪1.8b₪598.9m-₪96,977,854.0048.2x-18.7x3x
Mon, 27 Dec 2021₪2.0b₪559.8m-₪169,871,034.0050.6x-11.5x3.5x
Wed, 24 Nov 2021₪2.1b₪561.8m-₪158,898,266.0029.3x-13.5x3.8x
Fri, 22 Oct 2021₪2.2b₪522.6m-₪146,763,199.0028.3x-15x4.2x
Sun, 19 Sep 2021₪2.4b₪515.1m-₪150,123,489.0028.1x-15.8x4.6x
Tue, 17 Aug 2021₪2.2b₪499.0m-₪147,462,423.5026.8x-15.2x4.5x
Tue, 01 Jun 2021₪2.7b₪466.6m-₪189,880,366.5028.8x-14.2x5.8x
Fri, 05 Mar 2021₪2.2b₪442.0m-₪259,485,185.2023.6x-8.5x5x
Mon, 07 Dec 2020₪1.8b₪384.0m-₪288,523,540.9531.5x-6.3x4.7x
Thu, 10 Sep 2020₪1.7b₪328.9m-₪330,614,786.0044x-5.2x5.2x
Price to Earnings Ratio

-6.3x


Total Market Cap: ₪2.1bTotal Earnings: -₪330,614,786.00Total Revenue: ₪328.9mTotal Market Cap vs Earnings and Revenue0%0%0%
Israeli Pharma Industry Price to Earnings3Y Average -12.9x202120222023
Current Industry PE
  • Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 3.4x is higher than the industry's current PS ratio of 0.83x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 41% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Israeli Healthcare industry?

IL Market2.88%
Healthcare2.00%
Pharma-0.18%
Pharma-0.18%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
INCR InterCure₪7.422.3%
+₪7.5m
-65.1%PE10.7x
NXGN Nextgen Biomed₪0.544.8%
+₪1.1m
-50.1%PB1.9x
SEMG Seach Medical Group₪1.781.8%
+₪1.1m
-40.0%PS0.5x
PMCN Pharmocann Global₪0.2613.8%
+₪690.7k
-93.0%PS0.3x
PNAX Panaxia Labs Israel₪0.528.2%
+₪583.9k
-91.4%PS0.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

REKA

₪16.23

Rekah Pharmaceutical Industry

7D

-4.2%

1Y

-17.8%

INCR

₪7.42

InterCure

7D

2.3%

1Y

-65.1%

PPBT

₪0.65

Purple Biotech

7D

-1.4%

1Y

-32.5%

SEMG

₪1.78

Seach Medical Group

7D

1.8%

1Y

-40.0%

CSURE

₪0.37

Cannassure Therapeutics

7D

-22.2%

1Y

-88.2%

TKUN

₪0.27

Tikun Olam-Cannbit Pharmaceuticals

7D

-9.6%

1Y

-89.0%

PMCN

₪0.26

Pharmocann Global

7D

13.8%

1Y

-93.0%

NXGN

₪0.54

Nextgen Biomed

7D

4.8%

1Y

-50.1%